Autophagy-Circulating Tumor DNA Axis in Molecular Cancer Research: Emerging Mechanisms, Therapeutic Targeting, and...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Autophagy is a key cellular process regulating tumor viability, metabolism, and drug resistance.
• Circulating tumor DNA (ctDNA) is fragmented DNA released from dying tumor cells, detectable via blood tests for non-invasive cancer identification.
• Emerging evidence suggests a link between autophagy and ctDNA dynamics, termed the autophagy-ctDNA axis.

Purpose of the Study:

• To explore the mechanistic relationship between autophagy and circulating tumor DNA (ctDNA) dynamics.
• To present the autophagy-ctDNA axis as a hypothetical model for further investigation in cancer.
• To discuss the potential clinical implications of this interaction in cancer management.

Main Methods:

• Review of existing mechanistic evidence on autophagy's role in apoptosis, necrosis, and genomic instability.
• Analysis of how tumor microenvironment stressors influence autophagy and ctDNA release.
• Discussion of therapeutic targeting of autophagy and its potential impact on ctDNA levels.

Main Results:

• Autophagy modulation can influence ctDNA shedding: cytoprotective autophagy reduces DNA release, while inhibited autophagy increases it due to genomic instability.
• Tumor microenvironment factors like hypoxia and nutrient depletion can induce autophagy, indirectly affecting ctDNA.
• Pharmacological targeting of autophagy pathways (e.g., with chloroquine or mTOR inhibitors) may alter ctDNA concentrations.

Conclusions:

• The autophagy-ctDNA axis is a promising, yet under-investigated, area with potential for cancer biomarker development.
• Further mechanistic and translational research is needed to validate the clinical utility of targeting autophagy for ctDNA modulation.
• Understanding this axis could offer new strategies for cancer early detection, prognosis, and real-time treatment monitoring.